PHD FELLOWSHIP IN “IDENTIFICATION AND CHARACTERIZATION OF THE ANTIBACTERIAL ACTIVITY OF NEW PYRIMIDINE DERIVATIVES” AT CMD-COAT SA IN COLLABORATION WITH THE GIGA BIOMEDICAL RESEARCH INSTITUTE OF THE UNIVERSITY OF LIEGE

3 Jan 2024
Job Information

Organisation/Company

CMD-COAT

Research Field

Biological sciences » Other
Pharmacological sciences » Clinical pharmacology

Researcher Profile

First Stage Researcher (R1)

Country

Belgium

Application Deadline

15 Jan 2024 - 00:00 (Europe/Brussels)

Type of Contract

Temporary

Job Status

Full-time

Hours Per Week

38

Offer Starting Date

4 Dec 2023

Is the job funded through the EU Research Framework Programme?

HE / MSCA

Reference Number

HORIZON-MSCA-2021-DN-01

Marie Curie Grant Agreement Number

101072734

Is the Job related to staff position within a Research Infrastructure?

Yes

Offer Description

The PhD is part of the EU funded “Cell Envelope Anti-bacterials” Doctoral Network (CLEAR) www.clear.ku.dk

During your PhD Fellowship in the framework of CLEAR Doctoral Network, you will participate in the screening and characterization of antibacterial activity of compounds, patented by the University of Liege, against MRSA and C. difficile in vitro using a broad panel of strains, and relevant murine infections models (bacteremia, implant infection, endocarditis). You will work in close collaboration with other PhD of the CLEAR project for the determination of the mechanisms of action of these new compounds thanks to a collaboration with the University of Tuebingen (Germany) and examined their stability and efficacy in an in vitro gut model available at the University College Cork (Ireland).  

Requirements

Research Field

Biological sciences » Biology

Education Level

Master Degree or equivalent

Skills/Qualifications

• Master degree in biomedical, biological or pharmaceutical sciences. Please note that your master’s degree must be equivalent to a Belgian master’s degree (two years 120 ECTS/2 FTE MSc + 180 ECTS/3 FTE BSc).

      In addition, applicants will also be required to meet the MSCA Doctoral Network eligibility criteria, notably:

You must not have resided or carried out your main activity (work, studies, etc.) in Belgium for more than 12 months in the 36 months immediately before the start of your employment. Compulsory national service, short stays such as holidays, and time spent as part of a procedure for obtaining refugee status under the Geneva Convention are not taken into account.

• You must not be in possession of a doctoral degree when starting your employment.

• Desirable skills:

• Enthusiasm for research
• Collaborative, interactive mindset but capable of working independently
• Experience in pharmacology, cellular biology, or medical chemistry is of advantage.
• Languages:
• Good English skills, written and spoken

Specific Requirements

• The position as PhD fellow is full time and lasts 3 years. It is funded by Horizon Europe and will start the 1st of February 2024 (or 1st of April 2024 at the latest).

 

• The employment is conditioned upon the applicant’s successful enrolment as a PhD student at the Doctoral School at the Faculty of Medicine, University of Liège. This requires submission and acceptance of an application for the specific project to the Doctoral School.

 

• The PhD study must be completed in accordance with the Faculty’s rules on achieving the degree.

Languages

ENGLISH

Level

Good

Research Field

Biological sciences » Biology

Years of Research Experience

1 - 4

Additional Information

Website for additional job details

https://www.recherche.uliege.be/cms/c_9281209/en/mobilite-euraxess

Work Location(s)

Number of offers available

1

Company/Institute

CMD-COAT SA

Country

Belgium

State/Province

Liège

City

Liège

Postal Code

4000

Street

avenue de l'Hôpital 1

Where to apply

E-mail

[email protected]

Contact

State/Province

Liege

City

Liège

Website

http://www.cmd-coat.com

Street

avenue de l'Hôpital 1

Postal Code

4000

E-Mail

[email protected]

Phone

+3243662487

Mobile Phone

+32476937858

STATUS: EXPIRED